Modus Therapeutics Holding AB (ST:MODTX) — Stock Price
Modus Therapeutics Holding AB (ST:MODTX) is currently trading at Skr0.38 SEK, up 4.42% today. Over the past 52 weeks, shares have ranged between Skr0.27 and Skr3.09. This page tracks Modus Therapeutics Holding AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Modus Therapeutics Holding AB (MODTX) market capitalisation.
Modus Therapeutics Holding AB (MODTX) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Modus Therapeutics Holding AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.
Modus Therapeutics Holding AB Income Statement — Revenue, Profit & Earnings by Year
Modus Therapeutics Holding AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | Skr0.00 | Skr0.00 | Skr0.00 | Skr0.00 | Skr0.00 |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Research & Development | Skr10.85 Million | Skr9.07 Million | Skr8.48 Million | Skr10.90 Million | Skr13.54 Million |
| SG&A | Skr7.32 Million | Skr6.73 Million | Skr7.83 Million | Skr6.99 Million | Skr7.09 Million |
| Total Operating Expenses | Skr18.17 Million | Skr15.84 Million | Skr16.40 Million | Skr18.01 Million | Skr20.69 Million |
| Operating Income | Skr-18.17 Million | Skr-15.84 Million | Skr-16.40 Million | Skr-18.01 Million | Skr-20.69 Million |
| EBITDA | Skr-18.17 Million | Skr-15.84 Million | Skr2.00K | Skr-18.01 Million | Skr-20.69 Million |
| EBIT | — | — | Skr-16.40 Million | Skr-18.01 Million | Skr-20.69 Million |
| Interest Expense | Skr401.00K | Skr0.00 | Skr1.50 Million | Skr314.00K | Skr1.00K |
| Income Before Tax | Skr-18.54 Million | Skr-15.54 Million | Skr-17.90 Million | Skr-18.32 Million | Skr-20.69 Million |
| Income Tax Expense | — | — | Skr1.00 | Skr-18.01K | Skr1.00K |
| Net Income | Skr-18.54 Million | Skr-15.54 Million | Skr-17.90 Million | Skr-18.32 Million | Skr-20.69 Million |
Modus Therapeutics Holding AB Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Modus Therapeutics Holding AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | Skr12.69 Million | Skr4.88 Million | Skr20.04 Million | Skr11.27 Million | Skr21.19 Million |
| Total Current Assets | Skr12.69 Million | Skr4.83 Million | Skr19.99 Million | Skr11.22 Million | Skr21.14 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | Skr1.31 Million | Skr189.00K | Skr357.00K | Skr230.00K | Skr249.00K |
| Inventory | — | — | — | — | Skr-493.00 |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | Skr3.62 Million | Skr2.75 Million | Skr2.36 Million | Skr13.86 Million | Skr5.46 Million |
| Total Current Liabilities | Skr3.62 Million | Skr2.75 Million | Skr2.36 Million | Skr13.86 Million | Skr5.46 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | Skr-11.37 Million | Skr-4.38 Million | Skr-19.06 Million | Skr1.08 Million | Skr-20.65 Million |
| Total Stockholder Equity | Skr9.07 Million | Skr2.14 Million | Skr17.68 Million | Skr-2.58 Million | Skr15.73 Million |
| Retained Earnings | Skr-351.46 Million | Skr-332.92 Million | Skr-317.37 Million | Skr-299.48 Million | Skr-281.16 Million |
Modus Therapeutics Holding AB Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Modus Therapeutics Holding AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | Skr-18.07 Million | Skr-14.68 Million | Skr-16.68 Million | Skr-21.72 Million | Skr-16.08 Million |
| Capital Expenditures | Skr0.00 | Skr0.00 | Skr0.00 | Skr0.00 | Skr0.00 |
| Free Cash Flow | Skr-18.07 Million | Skr-14.68 Million | Skr-16.68 Million | Skr-21.72 Million | Skr-16.08 Million |
| Investing Cash Flow | — | — | — | — | Skr-50.00K |
| Financing Cash Flow | Skr25.07 Million | — | Skr25.32 Million | Skr11.50 Million | Skr29.43 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | — | — | — | — | — |
| Change in Cash | Skr6.99 Million | Skr-14.68 Million | Skr8.64 Million | Skr-10.22 Million | Skr13.30 Million |
Modus Therapeutics Holding AB Earnings History — EPS Actual vs. Analyst Estimates
Track Modus Therapeutics Holding AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Dec 31, 2025 | -0.04 | — | — |
| Sep 30, 2025 | -0.08 | — | — |
| Jun 30, 2025 | -0.07 | — | — |
| May 14, 2025 | -0.08 | — | — |
| Feb 20, 2025 | -0.13 | — | — |
| Nov 20, 2024 | -0.08 | — | — |
| Aug 23, 2024 | -0.13 | — | — |
| May 14, 2024 | -0.09 | — | — |